Procter & Gamble Logo
US7427181091
852062
PG

Procter & Gamble

Caricamento quotazioni...

Previsioni

Il prezzo obiettivo medio degli analisti è 155,49 € (-1,16%). La mediana è 152,70 € (-2,94%).

Acquista
  30
Mantieni
  22
Vendi
  1

Discussioni nella community

  • Tradotto (originale in tedesco)

    Un'azione. 20 anni. Nessuna vendita.

    Bakterius Bakterius II in Schnack

    12 41
  • Tradotto (originale in tedesco)

    Come gestire i titoli di qualitĂ  che non performano

    Das_Lama Das_Lama III in Schnack

    8 55
  • Gewinner laufen lassen/ Schäfchen ins Trockene bringen

    Parqet Nutzer Parqet Nutzer II in Schnack

    0 8
  • Tradotto (originale in tedesco)

    Dividendi regolari

    Bakterius Bakterius II in Schnack

    1 61
  • Eine Aktie fĂĽr die Ewigkeit! Welche wĂĽrdet ihr nehmen?

    MB Marc B. IV in Schnack

    2 20

  • Procter & Gamble impresses with 70 years of dividend growth and stable revenue

    Procter & Gamble has increased its dividend for 70 consecutive years and has paid uninterrupted dividends for 136 years. In the most recent quarter, revenue rose organically by 4 percent, and operating cash flow was $5.8 billion. In fiscal 2026, more than $10 billion was paid in dividends and around $5 billion went to share buybacks. The stock, with a forward P/E of about 24, is not cheap but—thanks to strong brands and stable cash flows—offers defensive stability compared with volatile tech names. » Altro su deraktionaer.de


  • Procter & Gamble confirms profit forecast despite sharply higher costs

    In the first fiscal quarter 2026/27, Procter & Gamble’s revenue rose 4.0% to USD 23.28 billion, with organic growth (adjusted) also at 4.0%; adjusted earnings per share climbed to USD 2.00 and beat expectations. The adjusted EBIT margin fell from 26.7% to 25.9% due to significantly higher raw material and transportation costs. Management slightly raised the sales outlook (2–4%), confirmed the adjusted EPS guidance of USD 6.89–7.11, and plans share buybacks and dividend payments of several billion dollars each; at the same time, higher raw material, interest and currency effects weighed on results. » Altro su finanzen.net


  • Procter & Gamble starts the 2026/27 fiscal year strongly

    The US consumer goods giant Procter & Gamble reported organic sales growth of 4% to $23.3 billion for the three months ended September, driven mainly by volumes with only modestly higher prices. Net income was about $4.7 billion, roughly flat year-on-year, and adjusted earnings per share rose 1% to $2.00. P&G confirmed its full-year targets: adjusted EPS to be flat to +3% ($6.89–$7.11) and organic sales growth of 1–3%; including the acquisition of Thorne, sales are expected to increase 2–4%. The stock rose just over 5% in early trading. » Altro su finanzen.net


  • Procter & Gamble hits 70th consecutive annual dividend increase amid steady fiscal 2026 results

    Procter & Gamble extended its dividend streak to 70 years and yields nearly 3%, supported by fiscal 2026 revenue of about $87 billion (up 3%) and EPS of $6.62 (up 2%). Moody's upgraded the company's credit outlook to positive, citing sustainable free cash flow and earnings growth. The stock is down roughly 8% year‑over‑year and trades at forward and trailing P/E ratios above 20, suggesting it is not inexpensive despite the reliable payout. » Altro su finance.yahoo.com


  • Moody’s raises outlook for Procter & Gamble to positive after strong cash flow

    Moody’s has confirmed the ratings for Procter & Gamble and Gillette (Aa3/Prime-1) and has raised the rating outlook from stable to positive. The change is justified by sustained free cash flow, strong earnings growth driven by price increases, innovation and cost reductions, and solid credit metrics (retained cash flow/net debt well above 25%, debt/EBITDA below 2). The acquisition of Thorne for USD 3.8 billion will pro forma temporarily increase the leverage ratio to just above 1.6x, but is expected to decline again through integration, scale effects and cost optimization. Moody’s cites potential upgrades or downgrades depending on market shares, profitability, free cash flow and the company’s financial policy. » Altro su de.investing.com

Nel 2026, Procter & Gamble ha già distribuito 2,77 € di dividendi. L'ultimo pagamento è avvenuto a agosto.

Dati finanziari dell'azienda

Nell'ultimo trimestre, Procter & Gamble ha registrato ricavi pari a 20,55 Mld € e un utile netto di 4,18 Mld €
(EUR) settembre 2026
YoY
Ricavi 20,55 Mld 7,72%
Utile lordo 10,24 Mld 4,50%
Utile netto 4,18 Mld 3,19%
EBITDA 6,23 Mld 4,55%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
357,73 Mld €
Numero di azioni
2,32 Mld
Massimo/minimo a 52 settimane
155,19 € - 125,09 €
Rendimento da dividendo
2,39%
Dividendi TTM
3,68 €
Prossimo dividendo
0,99 €
Beta
0,36
Rapporto P/E
25,16
Rapporto PEG
-6,32
Rapporto P/B
7,42
Rapporto P/S
4,48

Profilo aziendale

The Procter & Gamble Company fornisce prodotti di consumo confezionati di marca ai consumatori in Nord e Sud America, Europa, Asia Pacifico, Greater China, India, Medio Oriente e Africa. Opera in cinque segmenti: Beauty; Grooming; Health Care; Fabric & Home Care; e Baby, Feminine & Family Care. Il segmento Beauty offre balsami, shampoo, prodotti per lo styling e trattamenti; nonché antitraspiranti e deodoranti, prodotti per la detersione personale e per la cura della pelle con i marchi Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret e SK-II. The Procter & Gamble Company è stata fondata nel 1837 e ha sede a Cincinnati, Ohio.

Nome
Procter & Gamble
CEO
Shailesh G. Jejurikar
Sede centrale Cincinnati, oh
Stati Uniti
Sito web
Settore
Beni di prima necessitĂ 
Industria
Prodotti per la casa
Quotazione in borsa
02/01/1962
Dipendenti 104.000

Simboli di borsa

Borsa Simbolo
NYSE
PG
XETRA
PRG.DE
Frankfurt
PRG.F
DĂĽsseldorf
PRG.DU
Hamburg
PRG.HM
Milan
1PG.MI
London
0NOF.L
SIX
PG.SW
MĂĽnchen
PRG.MU
Wien
PG.VI
🍪

Parqet  usa i cookie. Scopri di più